News | October 15, 2021
Shilpa Medicare raises over Rs. 297 crore through preferential allotment
Equity raise to finance growth and investments in the biological space
Equity raise to finance growth and investments in the biological space
Compared to a net loss of Rs 12 crore in FY25, the pharma major reported a consolidated turnaround in its financial performance
Shares issued under ESOP 2008 and MESOP 2018 plans following exercise of vested stock options, in compliance with SEBI disclosure norms
Board approves allotment of shares to promoter Shankar Varadharajan following warrant conversion under SEBI Regulation 30 disclosure
Paid-up equity capital rises to Rs 973.19 crore following allotment to eligible employees
PLI scheme for Bulk Drugs has a total budgetary outlay of Rs. 6,940 crore
Medico Remedies receives order worth US$ 1,781,000
The company has projected Rs. 5,630 crores of investment and to provide employment to 6,350 people in three phases over a period of eight years
Karkinos is in the business of providing technology-driven, innovative solutions for the early detection, diagnosis, and management of cancer.
The Issue opened on June 18, 2024 and closed on June 21, 2024
Subscribe To Our Newsletter & Stay Updated
